Verteporfin inhibits growth of human glioma in vitro without light activation
Abstract Verteporfin (VP), a light-activated drug used in photodynamic therapy for the treatment of choroidal neovascular membranes, has also been shown to be an effective inhibitor of malignant cells. Recently, studies have demonstrated that, even without photo-activation, VP may still inhibit cert...
Enregistré dans:
Auteurs principaux: | Ahmad Al-Moujahed, Katarzyna Brodowska, Tomasz P. Stryjewski, Nikolaos E. Efstathiou, Ioannis Vasilikos, Joanna Cichy, Joan W. Miller, Evangelos Gragoudas, Demetrios G. Vavvas |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f2b0e6444b7e4b96bbf25cb0fb97f1fa |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization.
par: Hani Salehi-Had, et autres
Publié: (2011) -
Dramatic Reduction of Distant Pancreatic Metastases Using Local Light Activation of Verteporfin with Nab-Paclitaxel
par: Michael Pigula, et autres
Publié: (2021) -
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
par: Karim SP, et autres
Publié: (2013) -
Atorvastatin Promotes Phagocytosis and Attenuates Pro-Inflammatory Response in Human Retinal Pigment Epithelial Cells
par: Bo Tian, et autres
Publié: (2017) -
Local photoreceptor cell death differences in the murine model of retinal detachment
par: Daniel E. Maidana, et autres
Publié: (2021)